好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Anticipatory Autonomic responses in Patients with Postural Tachycardia Syndrome
Neuromuscular and Clinical Neurophysiology (EMG)
P5 - Poster Session 5 (8:00 AM-9:00 AM)
1-003
To examine anticipatory autonomic responses in patients with postural tachycardia syndrome (POTS). 

Patients with POTS experience tachycardia, palpitations, and shortness of breath on standing, which are attributed to baroreflex-mediated overactivation of the sympathetic nervous system. Autonomic anticipatory responses, which occur before the evoking stimulus is presented and are characteristic of classical conditioning, however, have not been investigated in these patients. 

We examined autonomic anticipatory responses in 28 adult patients who met criteria for POTS (unexplained tachycardia >30-bpm within 10 minutes of tilt in the absence of a fall in blood pressure) and 21 age/sex matched controls. Subjects completed the somatic vigilance questionnaire. Continuous blood pressure, electrocardiographic RR intervals, and end-tidal CO2 levels were measured while supine and during 60-degree head-up tilt. Plasma catecholamine levels were drawn through an indwelling forearm intravenous catheter. Thirty-seconds before tilt, subjects were warned that they were going to be tilted up. 

In patients with POTS, the onset of tachycardia preceded the movement of the tilt table, triggering a greater anticipatory heart rate increase while still supine (8±1 vs. 4±1 bpm, p=0.015). The magnitude of the anticipatory tachycardia was related to the severity of somatic vigilance scores (R=0.367, p=0.018) and the extent of hyperventilation during tilt (R=-0.352, p<0.022). Only POTS patients had a significant increase in circulating epinephrine when tilted (30±6 to 54±7 pg/ml, p<0.008). Compared to controls, tilt also induced a greater increase in norepinephrine levels (542±53 vs. POTS 644±56 pg/ml, p=0.018). 

The onset of tachycardia in POTS occurs prior to orthostatic stress and is related to mental attention to surveying bodily sensations. This anticipatory autonomic response suggests classic conditioning and a possible role for the amygdala-adrenal medulla neuronal circuitry in triggering a sympathoadrenal response with hyperventilation and tachycardia, which can be brought on by the thought of standing.    

Authors/Disclosures

PRESENTER
No disclosure on file
Jose-Alberto Palma, MD, PhD, FAAN (New York University Grossman School of Medicine) Dr. Palma has received personal compensation for serving as an employee of Eli Lilly. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care.
No disclosure on file
Celeste R. Camargo, MD Dr. Camargo has nothing to disclose.
Horacio C. Kaufmann, MD, FAAN (NYU Langone Health - NYU Dysautonomia Center) Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.